High-throughput structural biology of metabolic enzymes and its impact on human diseases.
The Structural Genomics Consortium (SGC) is a public-private partnership that aims to determine the three-dimensional structures of human proteins of medical relevance and place them into the public domain without restriction. To date, the Oxford Metabolic Enzyme Group at SGC has deposited the struc...
Auteurs principaux: | Yue, W, Oppermann, U |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2011
|
Documents similaires
-
High-throughput structural biology of metabolic enzymes and its impact on human diseases
par: Yue, W, et autres
Publié: (2011) -
High-throughput structural biology of metabolic enzymes and its impact on human diseases.
par: Yue, W, et autres
Publié: (2011) -
Structural genomics and high throughput structural biology /
par: Sundstrom, Michael, et autres
Publié: (2006) -
Structural genomics and drug discovery: Case studies on human metabolic enzymes
par: Oppermann, U, et autres
Publié: (2007) -
Molecular and structural aspects of xenobiotic carbonyl metabolizing enzymes. Role of reductases and dehydrogenases in xenobiotic phase I reactions.
par: Oppermann, U, et autres
Publié: (2000)